Transcranial magnetic stimulation (TMS) works for a meaningful percentage of people with depression, with response rates between 45% and 60% and full remission rates between 30% and 40%. Those numbers are particularly notable because most people who try TMS have already failed to improve on antidepressant medications. The American Psychiatric Association recognizes TMS as “a safe and effective evidence-based medical treatment,” and it now has FDA clearance for depression, OCD, and smoking cessation.
Response Rates for Depression
The two numbers that matter most when evaluating any depression treatment are the response rate (how many people experience at least a 50% reduction in symptoms) and the remission rate (how many people’s symptoms essentially disappear). For standard TMS protocols targeting the left prefrontal cortex, studies consistently report response rates of 45% to 60% and remission rates of 30% to 40%.
To put that in perspective, these patients have typically tried one or more antidepressants without adequate relief. A 2023 study looking specifically at people who had failed both an SSRI and an SNRI found that 63% responded to TMS and 42% achieved full remission. Another 15% had a partial response. So even among the hardest-to-treat patients, roughly three out of five saw their symptoms cut in half or more.
One interesting finding: TMS appears to work comparably whether or not you’re taking antidepressant medication at the same time. A retrospective study comparing outcomes in 100 patients found response rates of 80% without concurrent medication and 74% with it, a difference that was not statistically significant. Remission rates were similarly close at 64% and 58%. This suggests TMS can serve as either a standalone treatment or a complement to medication.
What the Treatment Looks Like
A standard course of TMS involves five sessions per week for about six weeks, totaling 30 to 36 sessions. Each session of conventional repetitive TMS lasts roughly 20 to 40 minutes. A newer protocol called intermittent theta burst stimulation (iTBS) delivers the same therapeutic effect in about 3 minutes per session, which has made treatment significantly more convenient.
The THREE-D clinical trial, one of the largest head-to-head comparisons, confirmed that this shorter theta burst protocol is equally effective as standard TMS for reducing depression symptoms, with benefits holding through 12 weeks of follow-up. A separate trial called BRIGhTMIND found the two approaches equally effective over 26 weeks. If your provider offers theta burst, there’s no trade-off in effectiveness for the shorter session time.
Most people don’t notice improvement right away. Some feel a shift within the first two weeks, but many don’t see meaningful changes until the fourth or fifth week. Clinical data suggest that the 15- to 20-session mark is when relief typically becomes noticeable, with full benefits emerging closer to the end of the six-week course. Early response is a good predictor of eventual outcome, so if you’re improving by the halfway point, chances are strong that you’ll continue to improve.
How Long the Benefits Last
A major naturalistic study followed 120 patients who had responded to TMS over a full year. At the 12-month mark, 62.5% of those who responded or remitted during the initial treatment course still met response criteria. The proportion in remission at the end of acute treatment remained similar at the end of the follow-up period.
This durability came with two caveats worth noting. Most patients continued taking antidepressant medication after their TMS course, and they had access to “reintroduction” TMS sessions if symptoms started creeping back. This is a realistic picture of how TMS works in practice: it’s not always a one-and-done cure, but it can create a lasting shift that’s maintained with standard follow-up care and occasional booster sessions.
Effectiveness for OCD
TMS for obsessive-compulsive disorder uses a different setup, targeting deeper brain structures with what’s called deep TMS. A multicenter randomized controlled trial published in the American Journal of Psychiatry found that 38.1% of patients receiving active deep TMS achieved a full response (at least a 30% drop in OCD symptom scores), compared to just 11.1% receiving a sham treatment. That gap widened at the one-month follow-up, with response rates climbing to 45.2% for the active group versus 17.8% for the sham group.
These numbers are more modest than the depression results, but OCD is notoriously difficult to treat, and many of these patients had already tried both medication and therapy. A response rate nearly four times higher than placebo, with continued improvement after treatment ends, represents a real option for people who haven’t found relief elsewhere.
Side Effects and Tolerability
One of TMS’s strongest selling points is how well people tolerate it. The most common side effects are headache and scalp discomfort during the session itself. In the pivotal clinical trial that led to FDA clearance, fewer than 5% of patients stopped treatment because of side effects. A separate trial sponsored by the National Institute of Mental Health found a nearly identical dropout rate of 5.5%, with most of those discontinuations caused by headaches.
Compare that to antidepressant medications, where side effects like weight gain, sexual dysfunction, and fatigue cause a substantial number of people to quit their prescriptions. TMS doesn’t enter the bloodstream, so it avoids systemic side effects entirely. The most serious risk, seizure, is extremely rare and occurs in fewer than 1 in 10,000 sessions.
Who Benefits Most
TMS is most commonly recommended after at least one antidepressant trial has failed, though it doesn’t require a long history of medication failures. The research suggests that people earlier in their treatment journey may actually respond better, since longer duration of illness and more failed treatments can reduce the likelihood of response to any intervention.
The treatment works by delivering magnetic pulses to the prefrontal cortex, the part of the brain involved in mood regulation that tends to be underactive in depression. It gradually restores normal activity patterns in that region. This mechanism is fundamentally different from medication, which is why TMS can work for people whose depression hasn’t budged with pills. It’s not a matter of trying harder with the same approach; it’s a genuinely different way of reaching the brain.